Philips is in the process of dispatching 25 of its image-guided therapy systems for acute stroke treatment to key regions of Ukraine including Dnipro, Zaporizhzha, and Odesa.

In collaboration with the World Bank and Ukraine’s Ministry of Health (MoH), the initiative is intended to meet Ukraine’s growing demand for stroke treatment and diagnosis, a matter that has been exacerbated by infrastructural damage and population displacement since Russia’s invasion of the nation in February 2022.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Working with partner AFS Medizintechnik to support the systems’ rollout, so far 19 of the Dutch  medtech giant’s interventional Azurion suites have been installed across sites in Ukraine.

Azurion can be used to support minimally invasive stroke treatments and procedures such as thrombectomy, which can potentially reverse the effects of long-term stroke paralysis. According to Philips, the suites integrate software tools and technologies that can streamline care pathways, reduce treatment delays, and improve patient outcomes. 

Philips’ chief medical officer, Carla Goulart Peron commented: “Every year, approximately 140,000 Ukrainians experience a stroke, with many facing disability or death due to delayed treatment.

“This collaboration ensures patients in underserved regions gain access to life-saving technologies.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

To maximise the benefits of the stroke network, the initiative also includes physician training. Set to take place in Poland, the initiative’s partners wanted to ensure physicians were up-to-speed with the latest in stroke treatment expertise.

Dr Dmytro Lebedynets, a neurologist at Feofaniya Clinical Hospital and consultant on stroke to the World Bank and Ukraine’s MoH, claimed the programme would “save lives, reduce disability, and changing the futures of stroke patients”.

“With these advanced tools, we can deliver timely and precise life-saving care, even in emergencies. It’s a game-changer for our patients. Now all the regions of our country will be able to provide the full spectrum of care to stroke patients,” said Lebedynets.

Stroke is a leading cause of death and disability worldwide. According to the World Stroke Organization, 1 in 4 individuals above the age of 25 will have a stroke in their lifetime.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact